Literature DB >> 22492321

Totally drug-resistant and extremely drug-resistant tuberculosis: the same disease?

G B Migliori, R Centis, L D'Ambrosio, A Spanevello, E Borroni, D M Cirillo, G Sotgiu.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22492321     DOI： 10.1093/cid/cis128

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN： 1058-4838            Impact factor:   9.079


× No keyword cloud information.
  15 in total

1.  The multidrug-resistant tuberculosis threat: old problems and new solutions.

Authors:  Giovanni Sotgiu; Lia D'Ambrosio; Rosella Centis; Ida Mura; Paolo Castiglia; Antonio Spanevello; Giovanni Battista Migliori
Journal:  J Thorac Dis       Date:  2015-09       Impact factor: 2.895

2.  Bedaquiline susceptibility test for totally drug-resistant tuberculosis Mycobacterium tuberculosis.

Authors:  Ji-Chan Jang; Yong-Gyun Jung; Jungil Choi; Hyunju Jung; Sungweon Ryoo
Journal:  J Microbiol       Date:  2017-04-20       Impact factor: 3.422

3.  Mycobacterium tuberculosis gyrase inhibitors as a new class of antitubercular drugs.

Authors:  Delia Blanco; Esther Perez-Herran; Mónica Cacho; Lluís Ballell; Julia Castro; Rubén González Del Río; José Luis Lavandera; Modesto J Remuiñán; Cindy Richards; Joaquin Rullas; María Jesús Vázquez-Muñiz; Ermias Woldu; María Cleofé Zapatero-González; Iñigo Angulo-Barturen; Alfonso Mendoza; David Barros
Journal:  Antimicrob Agents Chemother       Date:  2015-01-12       Impact factor: 5.191

4.  Mycobacterium tuberculosis-Secreted Protein, ESAT-6, Inhibits Lipopolysaccharide-Induced MMP-9 Expression and Inflammation Through NF-κB and MAPK Signaling in RAW 264.7 Macrophage Cells.

Authors:  Sun-Hyung Ha; Hyunju Choi; Jun-Young Park; Fukushi Abekura; Young-Choon Lee; Jeong-Ran Kim; Cheorl-Ho Kim
Journal:  Inflammation       Date:  2020-02       Impact factor: 4.092

5.  Thioridazine pharmacokinetic-pharmacodynamic parameters "Wobble" during treatment of tuberculosis: a theoretical basis for shorter-duration curative monotherapy with congeners.

Authors:  Sandirai Musuka; Shashikant Srivastava; Chandima Wasana Siyambalapitiyage Dona; Claudia Meek; Richard Leff; Jotam Pasipanodya; Tawanda Gumbo
Journal:  Antimicrob Agents Chemother       Date:  2013-09-16       Impact factor: 5.191

6.  Drug resistance beyond extensively drug-resistant tuberculosis: individual patient data meta-analysis.

Authors:  G B Migliori; G Sotgiu; N R Gandhi; D Falzon; K DeRiemer; R Centis; M G Hollm-Delgado; D Palmero; C Pérez-Guzmán; M H Vargas; L D'Ambrosio; A Spanevello; M Bauer; E D Chan; H S Schaaf; S Keshavjee; T H Holtz; D Menzies
Journal:  Eur Respir J       Date:  2012-10-11       Impact factor: 16.671

7.  Crystal structure and stability of gyrase-fluoroquinolone cleaved complexes from Mycobacterium tuberculosis.

Authors:  Tim R Blower; Benjamin H Williamson; Robert J Kerns; James M Berger
Journal:  Proc Natl Acad Sci U S A       Date:  2016-01-20       Impact factor: 11.205

8.  In Vitro Activity of β-Lactams in Combination with β-Lactamase Inhibitors against Multidrug-Resistant Mycobacterium tuberculosis Isolates.

Authors:  Dan Zhang; Yufeng Wang; Jie Lu; Yu Pang
Journal:  Antimicrob Agents Chemother       Date:  2015-11-02       Impact factor: 5.191

Review 9.  Protecting the tuberculosis drug pipeline: stating the case for the rational use of fluoroquinolones.

Authors:  Giovanni Battista Migliori; Miranda W Langendam; Lia D'Ambrosio; Rosella Centis; Francesco Blasi; Emma Huitric; Davide Manissero; Marieke J van der Werf
Journal:  Eur Respir J       Date:  2012-05-31       Impact factor: 16.671

Review 10.  Tuberculosis: From an incurable scourge to a curable disease - journey over a millennium.

Authors:  Surendra K Sharma; Alladi Mohan
Journal:  Indian J Med Res       Date:  2013-03       Impact factor: 2.375
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.